Table 2.
Diagnostic indices for screening diabetes with postload and baseline GA.
| Criteria | Sensitivity (%) | Specificity (%) | Positive predictive value (%) | Negative predictive value (%) |
|---|---|---|---|---|
| GA0 ≥ 16.3% | 67.5 (95% CI: 62.2–72.5%) | 83.4% (95% CI: 79.2–87.1%) | 79.3 (95% CI: 74.1–83.9%) | 73.2% (95% CI: 68.6–77.4%) |
| GA30 ≥ 16.4% | 68.1 (95% CI: 62.8–73.0%) | 81.5% (95% CI: 77.0–85.4%) | 77.6 (95% CI: 72.4–82.2%) | 73.1% (95% CI: 68.4–77.4%) |
| GA60 ≥ 16.4% | 69.3 (95% CI: 64.0–74.2%) | 80.6% (95% CI: 76.1–84.6%) | 77.1 (95% CI: 71.9–81.7%) | 73.6% (95% CI: 68.9–77.9%) |
| GA120 ≥ 16.3% | 71.6 (95% CI: 66.5–76.4%) | 83.4% (95% CI: 79.2–87.1%) | 80.3 (95% CI: 75.3–84.6%) | 75.8% (95% CI: 71.2–79.9%) |
| GA180 ≥ 16.2% | 69.3 (95% CI: 64.0–74.2%) | 86.0% (95% CI: 82.2–89.6%) | 82.6 (95% CI: 77.6–86.8%) | 74.9% (95% CI: 70.4–79.0%) |
GA: glycated albumin; CI: confidence interval.